This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 Jan 11;2(1):ltac001.

doi: 10.1093/immadv/ltac001. eCollection 2022.

Immunotherapy advances: One year on

Affiliations

PMID: 35919492
PMCID: PMC9327108
DOI: 10.1093/immadv/ltac001

Editorial

Immunotherapy advances: One year on

Tim Elliott. Immunother Adv. 2022.

. 2022 Jan 11;2(1):ltac001.

doi: 10.1093/immadv/ltac001. eCollection 2022.

Author

Affiliation

¹ Centre for Immuno-oncology, Nuffield Department of Medicine, University of Oxford, UK.

PMID: 35919492
PMCID: PMC9327108
DOI: 10.1093/immadv/ltac001

No abstract available

PubMed Disclaimer

Similar articles

Immunotherapy Advances: 2019.
Saleh N. Saleh N. Oncology (Williston Park). 2019 Oct 28;33(10):686508. Oncology (Williston Park). 2019. PMID: 31661150
Updates and Recent Advances on Venom Immunotherapy.
Floyd ML, Adams KE, Golden DBK. Floyd ML, et al. Curr Treat Options Allergy. 2023 Apr 29:1-19. doi: 10.1007/s40521-023-00336-7. Online ahead of print. Curr Treat Options Allergy. 2023. PMID: 37361640 Free PMC article. Review.
Advances in allergen immunotherapy in 2015.
Bush RK. Bush RK. J Allergy Clin Immunol. 2016 Nov;138(5):1284-1291. doi: 10.1016/j.jaci.2016.09.007. J Allergy Clin Immunol. 2016. PMID: 27817799 Review.
[Advances in Immunotherapy for Malignant Pleural Mesothelioma].
Chi Y, Liu Y, Zhao J. Chi Y, et al. Zhongguo Fei Ai Za Zhi. 2022 Apr 20;25(4):259-265. doi: 10.3779/j.issn.1009-3419.2022.101.17. Zhongguo Fei Ai Za Zhi. 2022. PMID: 35477190 Free PMC article. Chinese.
Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer.
Liu X, Li Z, Wang Y. Liu X, et al. Adv Biol (Weinh). 2021 Mar;5(3):e1900236. doi: 10.1002/adbi.201900236. Epub 2021 Jan 14. Adv Biol (Weinh). 2021. PMID: 33729700 Review.

See all similar articles

Cited by

Clinical and Experimental Immunology: highlights from 2022.
Taams LS, Taylor RS. Taams LS, et al. Clin Exp Immunol. 2023 Apr 7;212(1):11-13. doi: 10.1093/cei/uxad018. Clin Exp Immunol. 2023. PMID: 36805630 Free PMC article. No abstract available.

References

1. Markovska A, Schipper HS, Boes M.. Harnessing immunometabolism for cardiovascular health and cancer therapy. Immunother Adv 2021;1:1–3. - PMC - PubMed
1. O’Carroll SM, O’Neill LAJ.. Targeting immunometabolism to treat COVID-19. Immunother Adv 2021;1:1–10. - PMC - PubMed
1. Pallett LJ, Dimeloe S, Sinclair LV, et al. A glutamine ‘tug-of-war’: targets to manipulate glutamine metabolism for cancer immunotherapy. Immunother Adv 2021;1. DOI: 10.1093/IMMADV/LTAB010. - DOI - PMC - PubMed
1. Chambers ES, Vukmanovic-Stejic M, Turner CT, et al. Vitamin D3 replacement enhances antigen-specific immunity in older adults. Immunother Adv 2021;1:1–13. - PMC - PubMed
1. Mazzi MT, Hajdu KL, Ribeiro PR, et al. CAR-T cells leave the comfort zone: current and future applications beyond cancer. Immunother Adv 2021;1. DOI: 10.1093/IMMADV/LTAA006. - DOI - PMC - PubMed

Publication types

Actions

Grants and funding

28279/CRUK_/Cancer Research UK/United Kingdom

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central